| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |